Myopia 13
Networked: 3
relevant articles (0 outcomes,
1 trials/studies)
Disease Context: Research Results
Related Diseases
Experts
| 1. | Grauslund, Jakob:
1 article
(05/2013)
|
| 2. | Hjortdal, Jesper Ø:
1 article
(05/2013)
|
| 3. | Ivarsen, Anders:
1 article
(05/2013)
|
| 4. | Sjølie, Anne Katrin:
1 article
(05/2013)
|
| 5. | Vestergaard, Anders H:
1 article
(05/2013)
|
| 6. | Work, Kresten:
1 article
(05/2013)
|
| 7. | Cachulo, M Luz:
1 article
(03/2010)
|
| 8. | Carneiro, Angela:
1 article
(03/2010)
|
| 9. | Carvalheira, Fausto:
1 article
(03/2010)
|
| 10. | Murta, Joaquim N:
1 article
(03/2010)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Myopia 13:
| 1. | Retinaldehyde (Retinal)IBA
08/01/1996
- " Ocular findings in decreasing prevalence were the following: upward slanting of the palpebral fissure with the outer canthus 2 mm or higher than the inner canthus (82%), epicanthal folds (61%), astigmatism (60%), iris abnormalities (52%), strabismus (38%), lacrimal system obstruction (30%), blepharitis (30%), retinal abnormalities (28%), hyperopia (26%), amblyopia (26%), nystagmus (18%), cataract (13%), and myopia (13%). "
|
|
Therapies and Procedures